Loading...
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
The fixed-dose combination (FDC) elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/c/FTC/TDF) is a once-daily, single-tablet regimen containing an integrase strand transfer inhibitor and a pharmacoenhancer (cobicistat) associated with two nucleos(t)ide reverse transcriptase inhibitors. It is appr...
Na minha lista:
| Udgivet i: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4556264/ https://ncbi.nlm.nih.gov/pubmed/26345643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S88490 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|